Skip to content

Lifecore Biomedical, Inc. LFCR Cash Flow Statement

Q4 '26Q2 '26Q4 '25Q3 '25Q2 '25
-$14.98M-49.9%-$9.99M-771%-$1.15M+92.2%-$14.77M-125%-$6.57M+59.5%
$2.31M+16.6%$1.98M+3.5%$1.91M-7.8%$2.08M+1.6%$2.04M+2.6%
$1.7M-29.0%$2.39M+31.8%$1.82M-28.9%$2.55M-24.3%$3.37M+39.4%
$4.7M+167%$1.76M$1.2M+120%-$6.14M-902%
$1.12M-35.6%$1.74M-17.2%$2.1M-61.6%$5.46M+124%$2.44M-28.7%
-$1.12M+35.6%-$1.74M+17.2%-$2.1M-236%$1.54M+163%-$2.44M+28.7%
$36.4M+201%$12.1M$33.89M
-$256K+81.6%-$1.39M$0+100%-$6.78M-154%$12.52M+1,045%
$3.33M+344%-$1.36M-$4.04M-203%$3.94M+234%
$3.58M+14,228%$25K-$4.26M+50.4%-$8.58M-113%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Lifecore Biomedical, Inc. generate?
Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
What is Lifecore Biomedical, Inc.'s free cash flow?
After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
Where does Lifecore Biomedical, Inc.'s cash flow data come from?
Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.